DeltaNp73beta is active in transactivation and growth suppression.
about
p53 isoforms can regulate p53 transcriptional activity.The C terminus of p53 family proteins is a cell fate determinantIdentification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent mannerDeltaNp73 modulates nerve growth factor-mediated neuronal differentiation through repression of TrkATNF-alpha-mediated apoptosis in vascular smooth muscle cells requires p73Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expressionp73 as a pharmaceutical target for cancer therapyOverexpressed TP73 induces apoptosis in medulloblastomap63 and p73 transcriptionally regulate genes involved in DNA repair.The isoforms of the p53 proteinInteractions of the p53 protein family in cellular stress response in gastrointestinal tumorsDeltaNp73alpha regulates MDR1 expression by inhibiting p53 function.Suppression of acetylpolyamine oxidase by selected AP-1 members regulates DNp73 abundance: mechanistic insights for overcoming DNp73-mediated resistance to chemotherapeutic drugsDNA polymerase eta, the product of the xeroderma pigmentosum variant gene and a target of p53, modulates the DNA damage checkpoint and p53 activation.ΔNp73 enhances promoter activity of TGF-β induced genes.PUMA Cooperates with p21 to Regulate Mammary Epithelial Morphogenesis and Epithelial-To-Mesenchymal Transition.Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.Ubiquitin and ubiquitin-like modifications of the p53 family.p53 Family: Role of Protein Isoforms in Human Cancer.P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.p53 and p73 display common and distinct requirements for sequence specific binding to DNAMammary epithelial cell polarity is regulated differentially by p73 isoforms via epithelial-to-mesenchymal transition.p73, a sophisticated p53 family member in the cancer world.The functional domains in p53 family proteins exhibit both common and distinct properties.p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.TAp73 protein stability is controlled by histone deacetylase 1 via regulation of Hsp90 chaperone function.Hypoxia-induced DNp73 stabilization regulates Vegf-A expression and tumor angiogenesis similar to TAp73.TAp73beta and DNp73beta activate the expression of the pro-survival caspase-2Sp73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cellsTherapeutic prospects for p73 and p63: rising from the shadow of p53.TAp73β-mediated suppression of cell migration requires p57Kip2 control of actin cytoskeleton dynamicsRegulatory feedback loop between TP73 and TRIM32.Dysfunctional telomeres induce p53-dependent and independent apoptosis to compromise cellular proliferation and inhibit tumor formation.Identification of two p53 isoforms from Litopenaeus vannamei and their interaction with NF-κB to induce distinct immune response.Functions, divergence and clinical value of TAp73 isoforms in cancer.The role of the TP73 gene and its transcripts in neuro-oncology.p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.p73-Binding Partners and Their Functional Significance.p53- and p73-independent activation of TIGAR expression in vivo.
P2860
Q24319034-3ED183AB-4F7D-452E-81EC-D5B13201B8B7Q24556628-BEC9CBE1-8127-4EAC-BBDD-C674F686DC07Q28283017-E8C79619-81A4-4BEE-B67F-7F790526FF73Q28294595-59B8AD7E-73F8-450A-9A1F-6F15FFCF4CF9Q28573253-8C33E532-0641-4C37-BFD6-8E8A9E8BBE08Q28579894-2D6B69BA-14BD-4E51-A53B-98D137CCBD71Q28582632-0411C972-6F19-4E66-9D2F-D3AA49CCAD09Q28611414-6A38F66D-FAA7-4B2A-B16D-EAFB4C851765Q33290650-D1D139EC-C32C-4EB5-952F-899BB5FDA0C8Q33509508-FB7457F9-A8E1-4B16-9D50-1F7C1A3D2852Q33693832-43C27CF3-2A90-48C2-8823-86D2BF25884AQ33725939-94E28FD0-4F43-43A1-B075-2C793F36FD67Q33790804-D515D396-6800-4391-BCCB-7B83073F9170Q33858424-127AE195-7FA8-4E07-B3C4-FC3F3BA750F7Q34353609-1ACFD933-691F-43C4-AA82-AB7D3D537119Q34510516-064F8B07-F9C0-4EFF-B284-DA7671F58B73Q34785360-0ED3EE0A-9F22-477A-9B4C-22CEC7185D26Q34856099-02F6D6A2-F8EA-40E6-9438-4208D318BAA3Q35082705-72A75EF6-F606-45F9-92B4-4BE5C76B171FQ35326348-F745D966-A2AB-469C-9BDA-1B285D973311Q35359342-1EB4F863-C417-4EF9-8019-25E8390CAB64Q35646680-9064795A-D675-4677-93D9-8CD5DC6245CAQ36006937-75CD3316-92AB-4522-AB36-805644EBC0B8Q36306728-93B78EE0-B487-47CB-A4FA-2794A005ED5AQ36423942-54865832-1816-4760-8B57-B65C5891C98EQ36443527-70C752F5-EE37-47B3-A658-26A35CF09522Q36685194-DE049F13-00D8-4308-9189-C1DD15D95351Q36781069-3AD432B5-7591-48E7-A5A2-95D01EB729D9Q36798721-7E7B417B-9B32-4895-978E-804BB09FFADDQ36798725-9F212CAF-F2EB-492C-B3F6-4CD62A6C4BD1Q36979908-710DA9E5-17E0-4E73-A57C-A244F1B5C21EQ37016573-C1CBAE55-980C-45BF-B40E-EB7113A79B20Q37062004-A6437C6A-8A32-4ED1-AA9E-9693B5D68EC6Q37066979-03769B52-7C19-4A79-B6AB-899D6BEBCD88Q37731374-504CDF84-CADC-44F9-8B20-3B6F273A3E66Q38099613-9187EE0E-13C5-4BA9-98C4-E09263EAB2B4Q38205270-609DD0F3-FA60-4FE6-BA73-F359843712C0Q38333104-4D41C80F-69CA-4668-999B-0FDB694EFA2FQ38731186-23626AE3-7971-4C21-A075-DD4C553A224EQ38845932-AE4F61B2-B292-4C37-AD99-A43A5A9BA07D
P2860
DeltaNp73beta is active in transactivation and growth suppression.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
DeltaNp73beta is active in transactivation and growth suppression.
@en
type
label
DeltaNp73beta is active in transactivation and growth suppression.
@en
prefLabel
DeltaNp73beta is active in transactivation and growth suppression.
@en
P2093
P2860
P1476
DeltaNp73beta is active in transactivation and growth suppression
@en
P2093
Susan Nozell
Xinbin Chen
P2860
P304
P356
10.1128/MCB.24.2.487-501.2004
P407
P50
P577
2004-01-01T00:00:00Z